Skip to main content
. Author manuscript; available in PMC: 2025 Jul 1.
Published in final edited form as: Comput Biol Med. 2024 May 23;177:108643. doi: 10.1016/j.compbiomed.2024.108643

Table 1:

Patient demographics of datasets D1-D3. All the demographic information was available for cohorts D1, D2. Although cohort C had age information, they were specified as ranges. Hence median and interquartile range related statistics could not be calculated. No demographic information was available for dataset D4. μmol : micromoles; U : units; L : liter; ng: nanograms; mL: milliliter.

Variables D1 D2 D3
Age Median (IQR) 59 (47 – 67) 62 (53 – 72) -
Gender Male (%) 46.30 45.31 -
Laboratory findings Median (IQR)
Creatinine (Cr)(μmol/L) 60.0 (50.0 – 72.0) 99.0 (75.4 – 142.3) 84.4 (69.0 – 110.9)
Aspartate aminotransferase (AST)(U/L) 24.0 (19.0 – 37.0) 30.0 (21.0 – 47.0) 38.0 (26.0 – 61.0)
Alanine aminotransferase (ALT)(U/L) 23.0 (16.0 – 39.0) 21.0 (15.0 – 33.0) 30.0 (19.0 – 54.0)
Neutrophils count (Neu) (109 L−1) 3.63 (2.25 – 5.11) 4.82 (2.75 – 6.17) 5.3 (3.8 – 7.0)
Lymphocytes count (LYM) (109 L−1) 1.21 (0.88 – 1.68) 1.05 (0.77 – 1.30) 0.89 (0.65 – 1.36)
Procalcitonin (PCT)(ng/mL) 0.16 (0.055 – 0.24) 0.17 (0.08 – 0.54) 0.17 (0.09 – 0.34)